Specific human leucocyte antigen-DQ risk epitope mismatches are associated with chronic lung allograft dysfunction after lung transplantation
Open Access
- 11 April 2023
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (7) , 1009-1021
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantationThe Journal of Heart and Lung Transplantation, 2014
- De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantationThe Journal of Heart and Lung Transplantation, 2014
- Implications for Human Leukocyte Antigen Antibodies After Lung TransplantationChest, 2013
- Lung Transplantation in Patients with Pretransplantation Donor-Specific Antibodies Detected by Luminex AssayTransplantation, 2013
- Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLTThe Journal of Heart and Lung Transplantation, 2013
- Dynamic prediction by landmarking in competing risksStatistics in Medicine, 2012
- Landmark Analysis at the 25-Year Landmark PointCirculation: Cardiovascular Quality and Outcomes, 2011
- De Novo Donor HLA-Specific Antibodies after Heart Transplantation Are an Independent Predictor of Poor Patient SurvivalAmerican Journal of Transplantation, 2011
- HLA-Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft DysfunctionAmerican Journal of Transplantation, 2004
- Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.Transplantation, 2002